Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 183 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag

 		Immune Thrombocytopenia Switzerland NCT07587723

HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension

 		Elevated Blood Pressure, Hypertension Phase1 Japan NCT07644364

A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

 		Plaque Psoriasis, Metabolic Dysfunction-Associated Steatotic Liver Disease Spain NCT07683065

A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

 		Cryptosporidiosis Kenya
Malaysia
Zambia 		NCT07716410

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

 		Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Phase1, Phase2 Israel NCT07387926

A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan

 		Prostatic Neoplasms, Castration-Resistant United States NCT07677267

A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer

 		Prostatic Neoplasms, Castration-Resistant United States NCT07677254

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

 		Hidradenitis Suppurativa Phase3 Argentina
Australia 		NCT07665437

A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

 		Cardiovascular Diseases, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia, Familial Switzerland NCT07543731

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

 		Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy, Primary IgAN, Nephritis IgA Type, Nephropathy IgA Type Phase3 Japan NCT07498335